90 related articles for article (PubMed ID: 15533297)
61. The effect of inhibitors on the respiration of Leishmania donovani promastigotes from culture.
Ramasamy R
East Afr Med J; 1982 Jun; 59(6):379-82. PubMed ID: 7173076
[No Abstract] [Full Text] [Related]
62. Screening of metal ion chelators against Leishmania donovani-infected Syrian hamsters.
Mbati PA; Abok K; Anjili CO; Orago AS; Kagai JM; Githure JI; Koech DK
Afr J Health Sci; 1995 Feb; 2(1):223-227. PubMed ID: 12160448
[TBL] [Abstract][Full Text] [Related]
63. Effect of repeated administration of berenil on urinary enzyme excretion with corresponding tissue pattern in rats.
Akanji MA; Ngaha EO
Pharmacol Toxicol; 1989 Mar; 64(3):272-5. PubMed ID: 2726690
[TBL] [Abstract][Full Text] [Related]
64. Performance and consistency of a fluorescence-based high-throughput screening assay for use in Babesia drug screening in mice.
Rizk MA; El-Sayed SAE; AbouLaila M; Eltaysh R; Yokoyama N; Igarashi I
Sci Rep; 2017 Oct; 7(1):12774. PubMed ID: 29038534
[TBL] [Abstract][Full Text] [Related]
65. Effect of berenil on growth, mitochondrial DNA and respiration of Leishmania tarentolae promastigotes.
Leon W; Brun R; Krassner SM
J Protozool; 1977 Aug; 24(3):444-8. PubMed ID: 915848
[TBL] [Abstract][Full Text] [Related]
66. The Bo-RBC-SCID mouse model for evaluating the efficacy of anti-theilerial drugs.
Hagiwara K; Tsuji M; Ishihara C; Tajima M; Kurosawa T; Iwai H; Takahashi K
Int J Parasitol; 1993 Feb; 23(1):13-6. PubMed ID: 8468129
[TBL] [Abstract][Full Text] [Related]
67. In vitro activity and in vivo efficacy of a combination therapy of diminazene and chloroquine against murine visceral leishmaniasis.
Mwololo SW; Mutiso JM; Macharia JC; Bourdichon AJ; Gicheru MM
J Biomed Res; 2015 May; 29(3):214-23. PubMed ID: 26060445
[TBL] [Abstract][Full Text] [Related]
68. Diamidine compounds for selective inhibition of protein arginine methyltransferase 1.
Yan L; Yan C; Qian K; Su H; Kofsky-Wofford SA; Lee WC; Zhao X; Ho MC; Ivanov I; Zheng YG
J Med Chem; 2014 Mar; 57(6):2611-22. PubMed ID: 24564570
[TBL] [Abstract][Full Text] [Related]
69. Novel amidines and analogues as promising agents against intracellular parasites: a systematic review.
Soeiro MN; Werbovetz K; Boykin DW; Wilson WD; Wang MZ; Hemphill A
Parasitology; 2013 Jul; 140(8):929-51. PubMed ID: 23561006
[TBL] [Abstract][Full Text] [Related]
70. A novel organotellurium compound (RT-01) as a new antileishmanial agent.
Lima CB; Arrais-Silva WW; Cunha RL; Giorgio S
Korean J Parasitol; 2009 Sep; 47(3):213-8. PubMed ID: 19724693
[TBL] [Abstract][Full Text] [Related]
71. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections.
Miguel DC; Zauli-Nascimento RC; Yokoyama-Yasunaka JK; Katz S; Barbiéri CL; Uliana SR
J Antimicrob Chemother; 2009 Feb; 63(2):365-8. PubMed ID: 19095684
[TBL] [Abstract][Full Text] [Related]
72. Current treatment for cutaneous leishmaniasis: a review.
Palumbo E
Am J Ther; 2009; 16(2):178-82. PubMed ID: 19300044
[TBL] [Abstract][Full Text] [Related]
73. Miltefosine--discovery of the antileishmanial activity of phospholipid derivatives.
Croft SL; Engel J
Trans R Soc Trop Med Hyg; 2006 Dec; 100 Suppl 1():S4-8. PubMed ID: 16904717
[TBL] [Abstract][Full Text] [Related]
74. Efficacy of Trypan: a diminazene based drug as antileishmanial agent.
Macharia JC; Bourdichon AJ; Gicheru MM
Acta Trop; 2004; 92(3):267-72. PubMed ID: 15533297
[TBL] [Abstract][Full Text] [Related]
75. Activity, toxicity and analysis of resistance of essential oil from Chenopodium ambrosioides after intraperitoneal, oral and intralesional administration in BALB/c mice infected with Leishmania amazonensis: a preliminary study.
Monzote L; Montalvo AM; Scull R; Miranda M; Abreu J
Biomed Pharmacother; 2007; 61(2-3):148-53. PubMed ID: 17254746
[TBL] [Abstract][Full Text] [Related]
76. A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate.
Barroso PA; Marco JD; Calvopina M; Kato H; Korenaga M; Hashiguchi Y
J Antimicrob Chemother; 2007 Jun; 59(6):1123-9. PubMed ID: 17439977
[TBL] [Abstract][Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
